Search
Close this search box.

Fort Walton Medical Center offering antibody infusions for high-risk COVID patients

Fort Walton Beach Medical Center is now offering bamlanivimab antibody infusions to non-hospitalized patients who have tested positive for COVID-19 and have other high-risk factors.  The first patient received the treatment on December 22 making Fort Walton Beach Medical Center the only hospital in the tri-county area to offer this antibody infusion. The FDA granted Emergency Use Authorization […]

Fort Walton Beach Medical Center nurse administering the antibody infusion to a patient.

Fort Walton Beach Medical Center is now offering bamlanivimab antibody infusions to non-hospitalized patients who have tested positive for COVID-19 and have other high-risk factors. 

The first patient received the treatment on December 22 making Fort Walton Beach Medical Center the only hospital in the tri-county area to offer this antibody infusion.

The FDA granted Emergency Use Authorization of bamlanivimab for the treatment of COVID-19 patients experiencing mild to moderate symptoms who are high risk to develop severe COVID-19.  Fort Walton Beach Medical Center will provide the outpatient IV treatment for adults and adolescents age 12 and older.

High-risk conditions that may be eligible for this treatment include:

  • Obesity
  • 65+ years of age
  • Chronic kidney disease
  • COPD
  • Diabetes
  • Immunosuppressive disease
  • Heart disease
  • For children over the age of 12, sickle cell disease, neurodevelopmental disorders, and asthma are also among several additional considerations for eligibility.

“We’re committed to providing our patients, caregivers, and the communities we serve with the latest treatments in the fight against COVID-19 and are excited to bring this option to the tri-county area,” said Dr. Bob Kiskaddon, Chief Medical Officer for Fort Walton Beach Medical Center. “We will support all of our local hospitals in working closely with physicians and other providers across the communities we serve to provide treatment to patients who may benefit, per FDA guidelines.”

The medication supply is limited and based on availability. Patients will need a physician referral and meet FDA criteria prior to scheduling, according to the hospital.  The treatment is a one-time intravenous infusion over the course of one hour followed by an hour of monitoring.

bamlanivimab is not authorized for use for patients who:

  • Are hospitalized due to COVID-19
  • Require oxygen therapy due to COVID-19
  • Require supplemental oxygen for other conditions and require an increase in their oxygen requirement.

For more information on monoclonal antibody treatment for COVID-19, visit the Coronavirus Hub at www.fwbmc.com/covid-19.

Join the conversation...

Continue reading 👇

Community Comments

Tasha commented on sandy-royster
“Any updates on Sandy? Is been 7 months and news has been quiet about this. Hoping he has been found for the sake of the family.”
Respond
“Off the Walls Murals are awesome. They have also done Murals at Hilbert, Elgin and Blue Angels!”
Respond
“As A Chef I Love the Beal Parkway Store I Know All the Employees and I Always receive exceptional service There it is A Shame to take away this Store...”
Respond
“A very sad end for the Big U. But then again, her end mirrors that of the entire U.S. Flag merchant marine. This is coming from one who was privileged...”
Respond
“I have been in the Aldi's on Mary Esther Cutoff twice. There wasn't a single thing in the whole store that I would buy. Aldi's doesn't carry my essentials. I...”
Respond
“What about the $25,000,000 in debt that the City has now?”
Respond
“His medical degree is not relevant to this case. The other facts are indeed relevant.”
Respond
“Glad to see they will finally start recycling instead of taking our recycled which we are required to pay for to the dump!”
Respond
“We are going to be out of town that weekend, wish we were going to be here to attend.”
Respond
“In June 1954, my family sailed on the SS United States from New York to LaHavre, France. In Sept, we returned from England to New York. It was a fantastic...”
Respond